"/> Novus Biologicals™ Peptide bloquant d’anticorps Da… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Daxx

Réf. : BL-RE-047277Réf. fabricant : 18202296 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
1616
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77011. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the carboxy terminus of human Daxx.

Points forts

Source

Synthetic

(Accession #: CAG33366) The Daxx Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-047277
Réf. fabricant18202296
Gene ID (Entrez)1616
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77011. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneBING2, CENP-C binding protein, DAP6MGC126245, Daxx, death domain-associated protein 6, death-associated protein 6, death-domain associated protein, EAP1, ETS1-associated protein 1, Fas death domain-associated protein, Fas-binding protein, hDaxx, MGC126246
Symbole de gène(s)DAXX
Type de produitDaxx
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the carboxy terminus of human Daxx
Une question, une configuration particulière ?
Contactez-nous pour un devis.